Do pain-killers rubbed on the skin really work?

http://onlinelibrary.wiley.com/store/10.1002/14651858.CD008609.pub2/asset/CD008609.pdf?v=1&t=j3b6w4mf&s=0bd6b34afb736994196b787c2574b061cd035b66

From a trusted source, the Cochrane Collaboration. The authors reviewed 13 Cochrane Reviews published up to February, 2017, on the treatment of acute and chronic pain with a range of topical analgesics.

Most reviews compared the topical painkillers with topical placebo.

They were able to show with moderate to high quality evidence that topical NSIADs (diclofenac Emulgel, ketoprofen gel, piroxicam gel, diclofenac Flector plasters, and other diclofenac plasters) are effective (50% pain reduction in 20-50% of people), over 1 week, in the treatment of strains and sprains and (topical diclofenac and ketoprofen) to a lesser extent (50% pain reduction in 10-20% of people), over less than 6 to 12 weeks, in the treatment of hand and knee osteoarthritis. A single application of high-concentration topical capsaicin was shown with moderate quality evidence to have limited efficacy (50% pain reduction in 8.3% people), over 8-12 weeks, in the treatment of postherptic neuralgia.

There was low or very low quality evidence showing limited efficacy of other topical preparations leading to the conclusion that there is no good evidence to support any other topical pain killer for any other painful condition.

In the treatment of acute conditions topical NSAIDs caused no more systemic or local adverse events than placebo. In the treatment of chronic conditions topical capsaicin (itching or rash) and diclofenac, but not ketoprofen, were associated with more local adverse events than placebo.

The take-home message here is that specific topical painkilling preparations may be effective in the treatment of specific acute and chronic conditions with the authors high-lighting that the exact formulation used being possibly of critical importance.

The authors also high-lighted that the analgesic efficacy of topical analgesics is not just about rubbing them in, despite what is commonly believed. It may though go towards explaining the strong placebo effects noted in the reviews with the placebo preparations resulting in 50% or more improvements in pain in 20-57% of acute and 23-50% chronic conditions.

A systematic review and meta-analysis of interval training versus moderate-intensity continuous training on body adiposity.

http://onlinelibrary.wiley.com/doi/10.1111/obr.12536/abstract

An interesting article in Obesity Reviews comparing the effectiveness of high-intensity interval training (HIIT) and sprint interval training (SIT) with moderate-intensity continuous training (MICT). It presents level 1 evidence in the form of a systematic review and meta-analysis of 31 studies that concludes:
i. there is no difference in the body fat outcome between HIIT/SIT and MICT
ii. body fat reduction is more favourable with MICT than HIIT/SIT of lower time commitment and/or energy expenditure
iii. HIIT/SIT provides similar body fat reduction benefits to MICT but not in a more time-efficient manner
iv. neither HIIT/SIT nor MICT produce clinically meaningful reductions in body fat

The take home message is that HIIT/SIT is no more effective than MICT and these forms of exercise are not effective in reducing body fat. What we don't know is what effects these different forms of exercise have on other health outcomes such as blood pressure and blood lipid and sugar levels.

Despite these findings we need to though continue to advocate exercise to improve other overall health outcomes, even in the absence of weight loss, and improve the maintenance of weight loss as the result of lifestyle dietary interventions.

Finally, we need to stop making exercise complicated. It doesn't need to be one particular sort of exercise. What it does need to be is enjoyable for patients and clients, making it more readily adhered to, so it can become a part of a more active lifestyle.